NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/26/2022
Back to search
Official data from USPTO
CYPLEXINOL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
11/18/2022
Trademark type
Word
Nice classes
5
Filing date
08/22/2011
Registration date
06/12/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/26/2022
Last transaction
11/18/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/19/2011
First use in commerce
11/19/2011
Drawing code
4
Owner type
03
Owner location
SHREWSBURY, MA, US
Examiner
FLOWERS, JAY
Law office
M30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
ZYCAL BIOCEUTICALS HEALTHCARE COMPANY, INC.
ZyCal Bioceuticals, Inc.
ZyCal Bioceuticals, Inc.
Representatives
Andrew C. Aitken IP Law Leaders PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Orally ingested nutritional supplement
Publications
History of USPTO decisions and trademark events.
31 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/26/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/26/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/25/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
04/26/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/12/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/04/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/04/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/04/2017
E815
TEAS SECTION 8 & 15 RECEIVED
06/20/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/12/2017
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/29/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
06/12/2012
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/11/2012
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
05/10/2012
ALIE
ASSIGNED TO LIE
05/09/2012
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/23/2012
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/18/2012
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/18/2012
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/02/2012
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/02/2012
IUAF
USE AMENDMENT FILED
03/27/2012
EISU
TEAS STATEMENT OF USE RECEIVED
03/27/2012
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/13/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/17/2012
PUBO
PUBLISHED FOR OPPOSITION
01/17/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/28/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2011
DOCK
ASSIGNED TO EXAMINER
12/12/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/25/2011
NWAP
NEW APPLICATION ENTERED
08/25/2011
Continuous trademark protection
Get notified about every new filing that threatens CYPLEXINOL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.